Zurich-based distribution firm DKSH is reportedly among the bidders competing to acquire Swiss pharmaceutical distributor Swixx, according to sources familiar with the matter. The potential sale has garnered interest from various industry players as Swixx remains a significant player in the Swiss drug distribution sector.
Details about the valuation or the preferred terms of the possible acquisition have not been publicly disclosed. The process appears to be in its early stages, with no official confirmation from either company.
Swixx, known for its extensive distribution network within Switzerland, has attracted attention due to its strategic position in the pharmaceutical supply chain. The potential acquisition could impact the competitive landscape within the region’s healthcare distribution sector, depending on the outcome of the bids.
Both DKSH and other interested parties have yet to comment on the reports. The situation continues to develop as analysts and industry observers watch for further updates.